Targeting adenovirus with use of constrained peptide motifs

• US 5,846,782 A
• Filed: 08/21/1996
• Issued: 12/08/1998
• Est. Priority Date: 11/28/1995
• Status: Expired due to Term

• Current Assignee: Gen-Tech Incorporated
• Original Assignee: GenVec, Inc. (Precigen, Inc.)
• Inventors: Roelvink, Petrus W., Kovesdi, Imre, Wickham, Thomas J.
• Primary Examiner(s): Ketter, James
• Assistant Examiner(s): Yucel, Irem
• Application Number:
  US08/701,124
• Time in Patent Office: 839 Days
• Field of Search: 435/320.1, 435/172.3, 435/235.1, 435/69.7, 530/350
• US Class Current: 435/69.7
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: C07K 14/005 from viruses
• CPC Class Codes: C07K 2319/00 Fusion polypeptide
• CPC Class Codes: C12N 15/86 Viral vectors
• CPC Class Codes: C12N 2710/10322 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
• CPC Class Codes: C12N 2710/10343 viral genome or elements thereof as genetic vector
• CPC Class Codes: C12N 2710/10345 Special targeting system for viral vectors
• CPC Class Codes: C12N 2810/40 Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
• CPC Class Codes: C12N 2810/405 Vectors comprising RGD peptide
• CPC Class Codes: C12N 2810/60 from viruses
• CPC Class Codes: C12N 7/00 Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00

Abstract

The present invention provides a chimeric adenovirus fiber protein, which differs from the wild-type coat protein by the introduction of a nonnative amino acid sequence in a conformationally-restrained manner. Such a chimeric adenovirus fiber protein according to the invention is able to direct entry into cells of a vector comprising the chimeric fiber protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus fiber protein rather than the chimeric adenovirus fiber protein. The nonnative amino acid sequences encodes a peptide motif that comprises an epitope for an antibody, or a ligand for a cell surface receptor, that can be employed in cell targeting. The present invention also pertains to vectors comprising such a chimeric adenovirus fiber protein, and to methods of using such vectors.

Claims

1. A chimeric adenovirus fiber protein comprising a nonnative amino acid sequence that is constrained by a non-preexisting loop.

2. The chimeric adenovirus fiber protein of claim 1, wherein said chimeric adenovirus fiber protein directs entry into cells of a vector comprising said chimeric adenovirus fiber protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus fiber protein rather than said chimeric adenovirus protein.

3. The chimeric adenovirus fiber protein of claim 1, wherein said chimeric adenovirus fiber protein binds a binding site present on a cell surface which wild-type fiber protein does not bind.

4. The chimeric adenovirus fiber protein of claim 1, wherein said nonnative amino acid sequence comprises an epitope for an antibody or a ligand for a cell surface binding site.

5. The chimeric adenovirus fiber protein of claim 1, wherein said nonnative amino acid sequence comprises from about 3 to about 200 amino acids.

6. The chimeric adenovirus fiber protein of claim 5, wherein said nonnative amino acid sequence comprises from about 3 to about 30 amino acids.

7. The chimeric adenovirus fiber protein of claim 1, wherein said nonnative amino acid sequence comprises an RGD sequence and is constrained by one or more cysteine pairs that link together to form said non-preexisting loop.

8. The chimeric adenovirus fiber protein of claim 7, wherein said nonnative amino acid sequence is inserted into or in place of a protein sequence at the C-terminus of said chimeric adenovirus fiber protein.

9. The chimeric adenovirus fiber protein of claim 7, wherein said nonnative amino acid sequence comprises a sequence selected from the group consisting of SEQ ID NO:

3, SEQ ID NO;

4, and SEQ ID NO;

5, and wherein said sequence may be deleted at either the C- or N-terminus by 1, 2, or 3 residues.

10. The chimeric adenovirus fiber protein of claim 7, wherein said nonnative amino acid sequence comprises a sequence selected from the group consisting of SEQ ID NO:

3, SEQ ID NO;

4, SEQ ID NO;

5, and conservative amino acid substitutions thereof.

11. The chimeric adenovirus fiber protein comprising a nonnative amino acid sequence, wherein said nonnative amino acid sequence is constrained in a loop comprising a set of amino acid residues selected from the group consisting of residues 403-418, 441-453, 487-514, 522-528, 537-549, and 558-572.

12. A chimeric adenovirus fiber protein comprising a nonnative amino acid sequence, wherein said nonnative amino acid sequence is constrained by being inserted into or in place of a loop selected from the group consisting of the AB, CD, DG, GH, HI, and IJ loops of said chimeric adenovirus fiber protein.

13. The chimeric adenovirus fiber protein of claim 12, wherein said loop is selected from the group consisting of the AB, CD, DG, GH, and IJ loops.

14. The chimeric adenovirus fiber protein of claim 12, wherein said loop is the HI loop.

15. The chimeric adenovirus fiber protein of claim 12, wherein said loop does not comprise amino acid residues 400-402, 419-428, 431-440, 454-461, 479-482, 485-486, 516-521, 529-536, 550-557, and 573-578 of said fiber protein.

16. The chimeric adenovirus fiber protein of claim 12, wherein nonnative amino acid sequence comprises a sequence selected from the group consisting of SEQ IN NO:

1, SEQ ID NO;

2, SEQ ID NO;

3, SEQ ID NO;

4, SEQ ID NO;

5, SEQ ID NO;

17, SEQ ID NO;

19, SEQ ID NO;

23, SEQ ID NO;

31, SEQ ID NO;

35, SEQ ID NO;

39, SEQ ID NO;

43, SEQ ID NO;

49, SEQ ID NO;

53, SEQ ID NO;

56, SEQ ID NO;

59, SEQ ID NO;

63, SEQ ID NO;

66, SEQ ID NO;

67, SEQ ID NO;

68, SEQ ID NO;

79, and wherein said sequence may be deleted at either the C- or N-terminus by 1, 2, or 3 resides.

17. The chimeric adenovirus fiber protein of claim 12, wherein said nonnative amino acid sequence comprises a sequence selected from the group consisting of SEQ IN NO:

1, SEQ ID NO;

2, SEQ ID NO;

3, SEQ ID NO;

4, SEQ ID NO;

5, SEQ ID NO;

17, SEQ ID NO;

19, SEQ ID NO;

23, SEQ ID NO;

31, SEQ ID NO;

35, SEQ ID NO;

39, SEQ ID NO;

43, SEQ ID NO;

49, SEQ ID NO;

53, SEQ ID NO;

56, SEQ ID NO;

59, SEQ ID NO;

63, SEQ ID NO;

66, SEQ ID NO;

67, SEQ ID NO;

68, SEQ ID NO;

79, and conservative amino acid substitutions thereof.

18. The chimeric adenovirus fiber protein of claim 12, wherein said chimeric adenovirus fiber protein directs entry into cells of a vector comprising said chimeric adenovirus fiber protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus fiber protein rather than said chimeric adenovirus protein.

19. The chimeric adenovirus fiber protein of claim 12, wherein said chimeric adenovirus fiber protein binds a binding site present on a cell surface which wild-type fiber protein does not bind.

20. The chimeric adenovirus fiber protein of claim 12, wherein said nonnative amino acid sequence comprises an epitope for an antibody or a ligand for a cell surface binding site.

21. The chimeric adenovirus fiber protein of claim 12, wherein said nonnative amino acid sequence comprises from about 3 to about 200 amino acids.

22. The chimeric adenovirus fiber protein of claim 21, wherein said nonnative amino acid sequence comprises from about 3 to about 30 amino acids.

23. A method of increasing the affinity of a peptide for a cell surface binding site which comprises:

(a) obtaining a wild-type adenovirus fiber protein, and

(b) inserting into or in place of a protein sequence in a loop of said knob of said wild-type adenovirus fiber protein a nonnative amino acid sequence so as to result in a chimeric adenovirus fiber protein.

24. A method of increasing the affinity of a RGD sequence for a cell surface binding site which comprises:

(a) obtaining a wild-type adenovirus fiber protein, and

(b) inserting a RGD sequence into or in place of a protein sequence of said wild-type adenovirus fiber protein such that it is flanked by one or more cysteine pairs and is capable of forming a loop due to interaction between said cysteines.